Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR

Lai-Shan Tam¹, Yoshiya Tanaka², Rohini Handa³, Chi-Chen Chang⁴, Yew Kuang Cheng^{5

6}, Nazrul Isalm⁷, Mengtao Li⁸, Jose Paulo Lorenzo⁹, Yeong-Wook Song¹⁰, Kazuhiko Yamamoto¹¹, Xiaofeng Zeng⁸, Syed Atiqul Haq¹²

Affiliations

¹ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
² The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
³ Apollo Indraprastha Hospitals, New Delhi, India.
⁴ Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
⁵ Allergy, Arthritis & Rheumatism Clinic, Farrer Park Hospital, Singapore City, Singapore.
⁶ Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.
⁷ Deptartment of Rheumatology, BSMMU, Dhaka, Bangladesh.
⁸ Department of Rheumatology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Peking Union Medical College & Chinese Academy of Medical Science, Peking Union Medical College Hospital, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, Beijing, China.
⁹ Makati Medical Center, Makati, Philippines.
¹⁰ Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
¹¹ Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
¹² BSM Medical University, Dhaka, Bangladesh.

PMID: 32462761
PMCID: PMC7283887
DOI: 10.1111/1756-185X.13863

Review

Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR

Lai-Shan Tam et al. Int J Rheum Dis. 2020 Jun.

. 2020 Jun;23(6):717-722.

doi: 10.1111/1756-185X.13863. Epub 2020 May 27.

Authors

Affiliations

¹ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
² The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
³ Apollo Indraprastha Hospitals, New Delhi, India.
⁴ Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
⁵ Allergy, Arthritis & Rheumatism Clinic, Farrer Park Hospital, Singapore City, Singapore.
⁶ Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.
⁷ Deptartment of Rheumatology, BSMMU, Dhaka, Bangladesh.
⁸ Department of Rheumatology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Peking Union Medical College & Chinese Academy of Medical Science, Peking Union Medical College Hospital, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, Beijing, China.
⁹ Makati Medical Center, Makati, Philippines.
¹⁰ Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
¹¹ Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
¹² BSM Medical University, Dhaka, Bangladesh.

PMID: 32462761
PMCID: PMC7283887
DOI: 10.1111/1756-185X.13863

No abstract available

PubMed Disclaimer

Cited by

A Physician's Guide for Workers' Return to Work During COVID-19 Pandemic.
Baptista MC, Burton WN, Pawlecki B, Pransky G. Baptista MC, et al. J Occup Environ Med. 2021 Mar 1;63(3):199-220. doi: 10.1097/JOM.0000000000002118. J Occup Environ Med. 2021. PMID: 33350662 Free PMC article.
The impact of COVID-19 on rheumatology practice across Africa.
Akintayo RO, Akpabio AA, Kalla AA, Dey D, Migowa AN, Olaosebikan H, Bahiri R, El Miedany Y, Hadef D, Hamdi W, Oyoo O, Slimani S, Yerima A, Taha Y, Adebajo AO, Adelowo OO, Tikly M, Ghozlani I, Ben Abdelghani K, Fouad NA, Mosad D, El Mikkawy D, Abu-Zaid MH, Abdel-Magied RA. Akintayo RO, et al. Rheumatology (Oxford). 2021 Jan 5;60(1):392-398. doi: 10.1093/rheumatology/keaa600. Rheumatology (Oxford). 2021. PMID: 33020845 Free PMC article.
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis.
Tan EH, Sena AG, Prats-Uribe A, You SC, Ahmed WU, Kostka K, Reich C, Duvall SL, Lynch KE, Matheny ME, Duarte-Salles T, Bertolin SF, Hripcsak G, Natarajan K, Falconer T, Spotnitz M, Ostropolets A, Blacketer C, Alshammari TM, Alghoul H, Alser O, Lane JCE, Dawoud DM, Shah K, Yang Y, Zhang L, Areia C, Golozar A, Relcade M, Casajust P, Jonnagaddala J, Subbian V, Vizcaya D, Lai LY, Nyberg F, Morales DR, Posada JD, Shah NH, Gong M, Vivekanantham A, Abend A, Minty EP, Suchard M, Rijnbeek P, Ryan PB, Prieto-Alhambra D. Tan EH, et al. medRxiv [Preprint]. 2020 Nov 27:2020.11.24.20236802. doi: 10.1101/2020.11.24.20236802. medRxiv. 2020. Update in: Rheumatology (Oxford). 2021 Oct 9;60(SI):SI37-SI50. doi: 10.1093/rheumatology/keab250. PMID: 33269355 Free PMC article. Updated. Preprint.
Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.
Tam LS, Tanaka Y, Handa R, Li Z, Lorenzo JP, Louthrenoo W, Hill C, Pile K, Robinson PC, Dans LF, Hsu LY, Lee SM, Cho J, Hasan ATMT, Salim B, Samreen S, Shaharir SS, Wong P, Chau J, Danda D, Haq SA. Tam LS, et al. Int J Rheum Dis. 2021 Jun;24(6):733-745. doi: 10.1111/1756-185X.14124. Epub 2021 May 4. Int J Rheum Dis. 2021. PMID: 33945214 Free PMC article. Review.
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries.
Tan EH, Sena AG, Prats-Uribe A, You SC, Ahmed WU, Kostka K, Reich C, Duvall SL, Lynch KE, Matheny ME, Duarte-Salles T, Bertolin SF, Hripcsak G, Natarajan K, Falconer T, Spotnitz M, Ostropolets A, Blacketer C, Alshammari TM, Alghoul H, Alser O, Lane JCE, Dawoud DM, Shah K, Yang Y, Zhang L, Areia C, Golozar A, Recalde M, Casajust P, Jonnagaddala J, Subbian V, Vizcaya D, Lai LYH, Nyberg F, Morales DR, Posada JD, Shah NH, Gong M, Vivekanantham A, Abend A, Minty EP, Suchard M, Rijnbeek P, Ryan PB, Prieto-Alhambra D. Tan EH, et al. Rheumatology (Oxford). 2021 Oct 9;60(SI):SI37-SI50. doi: 10.1093/rheumatology/keab250. Rheumatology (Oxford). 2021. PMID: 33725121 Free PMC article.

See all "Cited by" articles

References

1. Furer V, Rondaan C, Heijstek M, et al. Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD open. 2019;5(2):e001041. - PMC - PubMed
1. Lewnard JA, Lo NC. Scientific and ethical basis for social‐distancing interventions against COVID‐19. Lancet Infect Dis. 2020.10.1016/S1473-3099(20)30190-0 - DOI - PMC - PubMed
1. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID‐ 19: a systematic review and meta‐analysis. Arch Acad Emerg Med. 2020;8(1):e35. - PMC - PubMed
1. Higham A, Bostock D, Booth G, Dungwa JV, Singh D. The effect of electronic cigarette and tobacco smoke exposure on COPD bronchial epithelial cell inflammatory responses. Int J Chron Obstruct Pulmon Dis. 2018;13:989‐1000. - PMC - PubMed
1. Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking upregulates angiotensin‐converting enzyme‐2 receptor: a potential adhesion site for novel coronavirus SARS‐CoV‐2 (Covid‐19). J Clin Med. 2020;9(3):841. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR

Affiliations

Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources